Micro-randomization trial design under operational constraints
Contemporary Clinical Trials · 2026-07 · 166 · 108351
DOI: 10.1016/j.cct.2026.108351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Contemporary Clinical Trials, 2026-07. Verfasst von Bryan Bunning und 11 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative Sciences Unit, Section of Biostatistics, Department of Medicine, Stanford University, Stanford, CA, USA; Computational Medicine, Departm…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Research Design, Hypoglycemic Agents, Randomized Controlled Trials as Topic. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Center for Advancing Translational Sciences, National Library of Medicine, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
BACKGROUND: Micro-randomization is a common method used to design and tailor AI-driven digital health interventions. However, applying it in real-world clinical settings can be challenging particularly when there are operational or resource constraints. We propose a novel design that integrates micro-randomization with treatment allocation policies to address such constraints, inspired by a pediatric type 1 diabetes (T1D) program. METHODS: We evaluated the design's properties through an extensive simulation study and developed a simulation-based power calculator, MRThreshold, to support such trial designs. RESULTS: Operational constraints that led to imbalance in treatment assignment affected efficiency. However, increasing resources had less impact relative to increases in study length (i.e., opportunities for micro-randomization). We observed a > 50% increase in power when lengthening a 16-week study to a 40-week study. Using our power calculator, we demonstrated that a 40-week study with 100 patients provides 84.0% power to detect a 2% change in time spent in glucose control, providing design considerations for our study. CONCLUSIONS: Careful consideration of study length, sample size, and operational capacity is essential for thoughtful design. Our novel design and tool balance micro-randomization and treatment allocation under operational constraints.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Quantitative Sciences Unit, Section of Biostatistics, Department of Medicine, Stanford University, Stanford, CA, USA; Computational Medicine, Department of Medicine, Stanford University, Stanford, CA, USA.
- Quantitative Sciences Unit, Section of Biostatistics, Department of Medicine, Stanford University, Stanford, CA, USA.
- Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, USA; Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA.
- Computational Medicine, Department of Medicine, Stanford University, Stanford, CA, USA; Clinical Excellence Research Center, Stanford University, Stanford, CA, USA.
- Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA; Department of Management Science and Engineering, Stanford University, Stanford, CA, USA.
- Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, USA; Stanford Diabetes Research Center, Stanford University, Stanford, CA, USA; Department of Management Science and Engi…
Förderung
- National Center for Advancing Translational Sciences
- National Library of Medicine
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Cancer Institute Division of Cancer Prevention
Zitieren
APA
Bunning, B., Ritter, V., Bishop, F. K., Chen, J. H., Ding, V., Johari, R., Shaw, B., Scheinker, D., Prahalad, P., Thapa, I., Maahs, D. M., & Desai, M. (2026). Micro-randomization trial design under operational constraints. Contemporary Clinical Trials, 166, 108351. https://doi.org/10.1016/j.cct.2026.108351
Vancouver
Bunning B, Ritter V, Bishop FK, Chen JH, Ding V, Johari R, et al. Micro-randomization trial design under operational constraints. Contemporary Clinical Trials. 2026;166:108351. doi:10.1016/j.cct.2026.108351
BibTeX
@article{Bunning2026,
author = {Bunning, Bryan and Ritter, Victor and Bishop, Franziska K and Chen, Jonathan H and Ding, Victoria and Johari, Ramesh and Shaw, Blake and Scheinker, David and Prahalad, Priya and Thapa, Isha and Maahs, David M and Desai, Manisha},
title = {Micro-randomization trial design under operational constraints},
journal = {Contemporary Clinical Trials},
year = {2026},
volume = {166},
pages = {108351},
doi = {10.1016/j.cct.2026.108351}
}
EUVIMED